Autologous Skeletal Myoblasts

· Mytogen, Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Autologous Skeletal Myoblasts, covering 2008-02-29 to 2012-06-08. Get the full timeline:

Most recent: Clinical Trial Update: Treatment With Autologous Skeletal Myoblasts [Phase 2]